β-Cell Autoantibodies and Their Function in Taiwanese Children With Type 1 Diabetes Mellitus

Journal of the Formosan Medical Association

Volumn 108, Issue 11, 2009, Pages 856-861

  Tung, Yi Ching ^a   Chen, Mei Huei ^b   Lee, Cheng Ting ^a   Tsai, Wen Yu ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CARDINAL TIEN HOSPITAL   (Taiwan)

Author keywords

autoantibodies; C peptide; glucagon test; type 1 diabetes mellitus

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUCAGON; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HEMOGLOBIN A1C; INSULIN; INSULIN ANTIBODY; INSULINOMA ANTIGEN 2 AUTOANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHILD; FEMALE; HUMAN; IMMUNOPATHOGENESIS; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ONSET AGE; PANCREAS ISLET BETA CELL; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; AGE FACTORS; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFANT; INSULIN-SECRETING CELLS; MALE;

EID: 71649089466     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60417-4     Document Type: Article

References (33)

1. Wei J.N., Sung F.C., Lin C.C., et al. National surveillance for type 2 diabetes mellitus in Taiwanese children. JAMA 290 (2003) 1345-1350
2. Tseng C.H., Tseng C.P., Chong C.K., et al. Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 49 (2006) 1755-1760
3. Tseng C.H. Incidence of type 1 diabetes in children aged 0-14 years during 1992-1998 in Taiwan. Acta Pediatr 97 (2008) 392-393
4. Esienbarth G.S. Type 1 diabetes: a chronic autoimmune disease. N Engl J Med 314 (1986) 1360-1368
5. Baekkeskov S., Aanstoot H.J., Christgau S., et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347 (1990) 151-156
6. Lan M.S., Wasserfall C., Maclaren N.K., et al. IA-2, a transmembrane protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 93 (1996) 6367-6370
7. Palmer J.P. Insulin autoantibodies: their role in the pathogenesis of IDDM. Diabetes Metab Rev 3 (1987) 1005-1015
8. Hagopian W.A., Sanjeevi C.B., Kockum I., et al. Glutamate decarboxylase-, insulin-and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95 (1995) 1501-1511
9. Bingley P.J., Bonifacio E., Williams A.J., et al. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46 (1997) 1701-1710
10. Gorus F.K., Goubert P., Semakula C., et al. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Diabetologia 40 (1997) 95-99
11. Diabetes Epidemiology Research International Group. Geographic pattern of childhood insulin-dependent diabetes mellitus. Diabetes 37 (1988) 1113-1119
12. Park Y. Why is type 1 diabetes uncommon in Asia. Ann N Y Acad Sci 1079 (2006) 31-40
13. Park Y., Lee H., Takino H., et al. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients. Acta Diabetol 38 (2001) 51-56
14. Sera Y., Kawasaki E., Abiru N., et al. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening. J Autoimmun 13 (1999) 257-265
15. Ko G.T.C., Chan J.C.N., Yeung V.T.F., et al. Autoantibodies to glutamic acid decarboxylase in young Chinese diabetic patients. Ann Clin Biochem 35 (1998) 761-767
16. Ng W.Y., Lee Y.S., Todd A.L., et al. Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: a study of Chinese patients with diabetes mellitus. Autoimmunity 35 (2002) 119-124
17. Chang Y.H., Shiau M.Y., Tsai S.T., et al. Autoantibodies against IA-2, GAD, and topoisomerase II in type 1 diabetic patients. Biochem Biophys Res Commun 320 (2004) 802-809
18. Chen B.H., Chung S.B., Chiang W., et al. GAD65 antibody prevalence and association with thyroid antibodies, HLADR in Chinese children with type a diabetes mellitus. Diabetes Res Clin Pract 54 (2001) 27-32
19. Wang J.P., Zhou Z.G., Lin J., et al. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives. Tissue Antigens 70 (2007) 369-375
20. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
21. Tanner J.M., and Whitehouse R.H. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51 (1976) 170-179
22. Tung Y.C., Lee J.S., Tsai W.Y., et al. Evaluation of β-cell function in diabetic Taiwanese children using a 6-minute glucagon test. Eur J Pediatr 167 (2008) 801-805
23. Bingley P.J., Bonifacio E., and Mueller P.W. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 52 (2003) 1128-1136
24. Sabbah E., Savoka K., Kulmala P., et al. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. J Clin Endocrinol Metab 84 (1999) 1534-1539
25. Graham J., Hagopian W.A., Kockum I., et al. Diabetes Incidence in Sweden Study Group; Swedish Childhood Diabetes Study Group: genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 51 (2002) 1346-1355
26. Feeney S.J., Myers M.A., Mackay I.R., et al. Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM. Diabetes Care 20 (1997) 1403-1407
27. Bilbao J.R., Rica I., Vázquez J.A., et al. Influence of sex and age at onset on autoantibodies against insulin, GAD65 and IA2 in recent onset type 1 diabetic patients. Horm Res 54 (2000) 181-185
28. Sochett E.B., Daneman D., Clarson C., et al. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children. Diabetologia 30 (1987) 453-459
29. Kimpimaki T., Kulmala P., Savola K., et al. Natural history of β-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 87 (2002) 4572-4579
30. Stene L.C., Witsø E., Torjesen P.A., et al. Islet autoantibody development during follow-up of high-risk children from the general Norwegian population from three months of age: design and early results from the MIDIA study. J Autoimmun 9 (2007) 44-51
31. Hoeldtke R.D., Bryner K.D., Horvath G.G., et al. Antibodies to GAD and glycemic control in recent-onset IDDM. Diabetes Care 20 (1997) 1900-1903
32. Petersen J.S., Dyrberg T., Karlsen A.E., et al. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group. Diabetes 43 (1994) 1291-1296
33. Decochez K., Keymeulen B., Somers G., et al. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Diabetes Care 23 (2000) 1072-1078